. "Incontinence and menopause"@en . . "CZ - \u010Cesk\u00E1 republika" . "1" . "1"^^ . . . . . "\u010Cl\u00E1nek pojedn\u00E1v\u00E1 o probl\u00E9mu mo\u010Dov\u00E9 inkontinence u \u017Een v obdob\u00ED klimakteria. Samovoln\u00ED nekontrolovateln\u00FD \u00FAnik mo\u010Di - mo\u010Dov\u00E1 inkontinence - postihuje v pr\u016Fb\u011Bhu \u017Eivota a\u017E 50 % \u017Een. Nejrizikov\u011Bj\u0161\u00ED skupinou jsou \u017Eeny v obdob\u00ED kolem menopauzy a po n\u00ED. Postupn\u00E1 ztr\u00E1ta funkce vaje\u010Dn\u00EDk\u016F m\u00E1 za n\u00E1sledek pokles hladiny estrogen\u016F. Estrogenn\u00ED deficit zp\u016Fsobuje atrofii tk\u00E1n\u00ED uropoetick\u00E9ho traktu se v\u0161emi d\u016Fsledky, v\u010Detn\u011B vzniku \u010Di zhor\u0161en\u00ED mo\u010Dov\u00E9 inkontinence. Hormon\u00E1ln\u00ED substituce estrogen\u016F m\u00E1 prok\u00E1zan\u00FD pozitivn\u00ED vliv na zv\u00FD\u0161en\u00ED kvality \u017Eivota pacientek i zlep\u0161en\u00ED jejich obt\u00ED\u017E\u00ED, a\u0165 ji\u017E v monoterapii \u010Di v kombinaci s dal\u0161\u00EDmi mo\u017Enostmi l\u00E9\u010Dby inkontinence."@cs . "2"^^ . . "RIV/00064173:_____/11:00002858" . "[F87FC884A02A]" . . "http://www.urologiepropraxi.cz/pdfs/uro/2011/01/05.pdf" . "12" . "\u010Cl\u00E1nek pojedn\u00E1v\u00E1 o probl\u00E9mu mo\u010Dov\u00E9 inkontinence u \u017Een v obdob\u00ED klimakteria. Samovoln\u00ED nekontrolovateln\u00FD \u00FAnik mo\u010Di - mo\u010Dov\u00E1 inkontinence - postihuje v pr\u016Fb\u011Bhu \u017Eivota a\u017E 50 % \u017Een. Nejrizikov\u011Bj\u0161\u00ED skupinou jsou \u017Eeny v obdob\u00ED kolem menopauzy a po n\u00ED. Postupn\u00E1 ztr\u00E1ta funkce vaje\u010Dn\u00EDk\u016F m\u00E1 za n\u00E1sledek pokles hladiny estrogen\u016F. Estrogenn\u00ED deficit zp\u016Fsobuje atrofii tk\u00E1n\u00ED uropoetick\u00E9ho traktu se v\u0161emi d\u016Fsledky, v\u010Detn\u011B vzniku \u010Di zhor\u0161en\u00ED mo\u010Dov\u00E9 inkontinence. Hormon\u00E1ln\u00ED substituce estrogen\u016F m\u00E1 prok\u00E1zan\u00FD pozitivn\u00ED vliv na zv\u00FD\u0161en\u00ED kvality \u017Eivota pacientek i zlep\u0161en\u00ED jejich obt\u00ED\u017E\u00ED, a\u0165 ji\u017E v monoterapii \u010Di v kombinaci s dal\u0161\u00EDmi mo\u017Enostmi l\u00E9\u010Dby inkontinence." . . "Incontinence and menopause"@en . . "4"^^ . . "Trn\u011Bn\u00E1, Zuzana" . "Inkontinence a menopauza"@cs . "V" . "Inkontinence a menopauza" . . "Inkontinence a menopauza"@cs . . . "1213-1768" . "RIV/00064173:_____/11:00002858!RIV13-MZ0-00064173" . "The review deals with urinary incontinence in climacteric women. Urinary incontinence, an involuntary/uncontrolled leakage of urine, affects up to fifty percent of women at some point in their lives. The groups with the highest risk are peri- and postmenopausal women. The gradual loss of ovarian function results in decreased oestrogen levels. Oestrogen deficiency causes the tissues of the uropoietic system to atrophy with all its implications, including the development or impairment of urinary incontinence. Oestrogen hormone replacement therapy has been shown to have a positive impact on increasing the quality of life of patients as well as improving their complaints, whether in monotherapy or in combination with other treatment options for incontinence."@en . "Urologie pro praxi" . . "parasympatolytics; urogenital atrophy; oestrogens; menopause; incontinence"@en . . "204893" . "Inkontinence a menopauza" . .